These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

219 related items for PubMed ID: 9312186

  • 1. Oral magnesium supplements reduce erythrocyte dehydration in patients with sickle cell disease.
    De Franceschi L, Bachir D, Galacteros F, Tchernia G, Cynober T, Alper S, Platt O, Beuzard Y, Brugnara C.
    J Clin Invest; 1997 Oct 01; 100(7):1847-52. PubMed ID: 9312186
    [Abstract] [Full Text] [Related]

  • 2. Modulation of erythrocyte potassium chloride cotransport, potassium content, and density by dietary magnesium intake in transgenic SAD mouse.
    De Franceschi L, Beuzard Y, Jouault H, Brugnara C.
    Blood; 1996 Oct 01; 88(7):2738-44. PubMed ID: 8839870
    [Abstract] [Full Text] [Related]

  • 3. The effect of dietary magnesium supplementation on the cellular abnormalities of erythrocytes in patients with beta thalassemia intermedia.
    De Franceschi L, Cappellini MD, Graziadei G, Manzato F, Olivieri O, Corrocher R, Fiorelli G, Beuzard Y, Brugnara C.
    Haematologica; 1998 Feb 01; 83(2):118-25. PubMed ID: 9549922
    [Abstract] [Full Text] [Related]

  • 4. Sickle cell disease: from membrane pathophysiology to novel therapies for prevention of erythrocyte dehydration.
    Brugnara C.
    J Pediatr Hematol Oncol; 2003 Dec 01; 25(12):927-33. PubMed ID: 14663274
    [Abstract] [Full Text] [Related]

  • 5. Erythrocyte dehydration in pathophysiology and treatment of sickle cell disease.
    Brugnara C.
    Curr Opin Hematol; 1995 Mar 01; 2(2):132-8. PubMed ID: 9371983
    [Abstract] [Full Text] [Related]

  • 6. Membrane transport of Na and K and cell dehydration in sickle erythrocytes.
    Brugnara C.
    Experientia; 1993 Feb 15; 49(2):100-9. PubMed ID: 8440348
    [Abstract] [Full Text] [Related]

  • 7. Oral magnesium pidolate: effects of long-term administration in patients with sickle cell disease.
    De Franceschi L, Bachir D, Galacteros F, Tchernia G, Cynober T, Neuberg D, Beuzard Y, Brugnara C.
    Br J Haematol; 2000 Feb 15; 108(2):284-9. PubMed ID: 10691856
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Hydration of sickle cells using the sodium ionophore Monensin. A model for therapy.
    Clark MR, Mohandas N, Shohet SB.
    J Clin Invest; 1982 Nov 15; 70(5):1074-80. PubMed ID: 7130394
    [Abstract] [Full Text] [Related]

  • 10. In vitro exposure to hydroxyurea reduces sickle red blood cell deformability.
    Huang Z, Louderback JG, King SB, Ballas SK, Kim-Shapiro DB.
    Am J Hematol; 2001 Jul 15; 67(3):151-6. PubMed ID: 11391710
    [Abstract] [Full Text] [Related]

  • 11. Therapeutic strategies for prevention of sickle cell dehydration.
    Brugnara C.
    Blood Cells Mol Dis; 2001 Jul 15; 27(1):71-80. PubMed ID: 11358364
    [Abstract] [Full Text] [Related]

  • 12. Effect of hydroxyurea on the rheological properties of sickle erythrocytes in vivo.
    Ballas SK, Dover GJ, Charache S.
    Am J Hematol; 1989 Oct 15; 32(2):104-11. PubMed ID: 2757007
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Phase I study of magnesium pidolate in combination with hydroxycarbamide for children with sickle cell anaemia.
    Hankins JS, Wynn LW, Brugnara C, Hillery CA, Li CS, Wang WC.
    Br J Haematol; 2008 Jan 15; 140(1):80-5. PubMed ID: 17991298
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.